James Powell, MD
Endocrinology, Diabetes & Metabolism · Hattiesburg, MSNPI 1164523932
Payments from drug & device makers
Across 642 payments — averaging $137.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$80K
- Lilly USA, LLC$843
- Novo Nordisk$811
- Sanofi-aventis U.S. LLC$807
- Abbott$802
- Boehringer Ingelheim$642
- plus $4K from 32 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 173 | $80,416 |
| Lilly USA, LLC | 54 | $843 |
| Novo Nordisk | 55 | $811 |
| Sanofi-aventis U.S. LLC | 43 | $807 |
| Abbott | 44 | $802 |
| Boehringer Ingelheim | 38 | $642 |
| Dexcom, Inc. | 29 | $605 |
| AbbVie | 32 | $517 |
| AstraZeneca | 18 | $265 |
| Medtronic(2 entities) | 16 | $217 |
| Bayer | 10 | $173 |
| Radius Health, Inc. | 10 | $170 |
| Insulet Corporation | 7 | $157 |
| Xeris Pharmaceuticals, Inc. | 7 | $153 |
| Tandem Diabetes Care, Inc. | 8 | $135 |
| Merck | 9 | $127 |
| Novartis | 7 | $116 |
| Pfizer | 7 | $115 |
| Johnson & Johnson | 7 | $107 |
| Lifescan, Inc. | 8 | $107 |
| Sequel Med Tech, LLC | 5 | $102 |
| BD | 6 | $98 |
| Corcept Therapeutics | 6 | $93 |
| Ascendis Pharma Endocrinology Inc | 5 | $91 |
| IBSA Pharma Inc. | 5 | $88 |
| Regeneron Healthcare Solutions, Inc. | 5 | $87 |
| BETA Bionics, Inc. | 3 | $85 |
| Amarin Pharma, Inc. | 6 | $85 |
| Recordati_rare_diseases_inc. | 3 | $61 |
| GRT US Holding, Inc. | 4 | $59 |
| Amneal Pharmaceuticals LLC | 4 | $53 |
| RGH Enterprises LLC | 1 | $40 |
| Shire North American Group Inc | 2 | $32 |
| Averitas Pharma Inc. | 1 | $31 |
| Neurocrine Biosciences, Inc. | 1 | $19 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Acerus Pharmaceuticals Corporation | 1 | $16 |
| Dynavax Technologies Corporation | 1 | $9 |
How this compares
$88,351 in reported general payments places this provider in the 80th percentile of 48 endocrinology, diabetes & metabolism providers in Mississippi.
See all endocrinology, diabetes & metabolism providers in Mississippi →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Hattiesburg
- Richard GallowayHattiesburg$109K
- Jaya NaranHattiesburg$3K
- Aboorva Kambiliampatti SudhakarHattiesburg$1K
- Daniel McCallHattiesburg$1K
- Dana DaleHattiesburg$300
- Mark BorcheltGulfport$1.1M
- Honey EastJackson$904K
- Eric DyessJackson$885K
- Ben SealeJackson$623K
- Jeremy TaylorMadison$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.